You are here:
my luxmed account
Customise the font: A A A

Vaccination offer

To get the vaccination, book an appointment for a medical qualification
by calling 81 532 37 11.
Remember that the qualification is valid for 24 hours
from the time it is issued.

Meningococcus type B (Bexsero)

  • Indications for use:
    Bexsero vaccine is indicated for the active immunisation of children from 2 months of age, adolescents and adults against invasive meningococcal disease caused by Neisseria meningitidis group B. These bacteria can cause severe, life-threatening infections such as sepsis and meningitis.
  • Age indications:
    from 2 months to 50 years
  • Vaccination cycle:
    • from 2 months to 5 months of age - 3 doses not less than 1 month apart, a booster dose between 12-23 months of age,
    • children from 6 months to 11 months of age - 2 doses not less than 2 months apart, a booster dose at 2 years of age,
    • children from 12 months to 23 months - 2 doses not less than 2 months apart, booster dose 12-23 months after the primary vaccination,
    • children from 2 years old to 10 years old - 2 doses not less than 2 months apart, no booster dose,
    • children from 11 years of age and adults - 2 doses not less than 1 month apart, no booster dose,
    • Qualification required before each dose.
  • Vaccination price (one dose): PLN 390.00

Meningococci A, C, W135, Y (Nimenrix)

  • Indication for use:
    Nimenrix is a vaccine for the active immunisation of children (over 1 year of age), adolescents and adults exposed to Neisseriameningitidis serogroups A, C, W135 and Y; for the prevention of invasive disease. The meningitis bacteria can cause serious, sometimes life-threatening infections, such as meningitis and septicaemia (blood infection).
  • Persons to whom vaccination is particularly recommended:
    • Persons residing in endemic areas
    • Schoolchildren
    • Children
  • Age indications:
    over 1 year of age.
  • Vaccination cycle:
    1 dose. Qualification required.
  • Vaccination price: 210.00 zł

Meningococci A, C, W135, Y (Menveo)

  • Indications for use:
    Menveo is a vaccine for the active immunisation of children (over 2 years of age), adolescents and adults exposed to Neisseriameningitidis serogroups A, C, W135 and Y; for the prevention of invasive disease. The meningitis bacteria can cause serious, sometimes life-threatening infections, such as meningitis and septicaemia (blood infection).
  • Persons to whom vaccination is particularly recommended:
    • Persons residing in endemic areas
    • Schoolchildren
    • Children
  • Age indications:
    from 2 years ofageto 65 years of age.
  • Vaccination cycle:
    1 dose. Qualification required.
  • Vaccination price: £195.00

Meningokoki typ C (Neisvac C) - niedostępna do lutego 2023

  • Indications for use:
    Neisvac C is a vaccine for active immunization of children over 2 months of age, adolescents and adults against infections caused by Neisseria meningitidis group C. The vaccine does not protect against infections caused by meningococci of other groups.
  • Age indications:
    after 2 months of age
  • Vaccination cycle:
    • from 2 months of age to 12 months - 2 doses (the second dose 2 months after the first)
    • children over 1 year of age, adults - 1 dose
    • Qualification required before each dose.
  • Duration of immunity:
    For life
  • Vaccination price (one dose): 157.00 zł